Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have taken part in and received treatment through a GBG (German Breast Group) clinical trial for early-stage breast cancer.
- People who have given written consent before any data or biological samples are collected, following local regulations.
Who may not be able to join:
- People who participated in and received treatment through a non-GBG clinical trial for early-stage breast cancer.
- People with advanced or metastatic (spread) breast cancer who took part in and received treatment through a GBG clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sibylle Loibl, Prof. Dr., GBG Forschungs GmbH
Phone: 0049610274800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival (DFS); Invasive disease-free survival (iDFS); Distant disease-free survival (DDFS); Locoregional recurrence-free survival (LRRFS); Overall survival (OS); Other primary outcome measures
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.